首页> 外文期刊>CNS neuroscience & therapeutics >Tacrine-6-Ferulic Acid, a Novel Multifunctional Dimer Against Alzheimer's Disease, Prevents Oxidative Stress-Induced Neuronal Death Through Activating Nrf2/ARE/HO-1 Pathway in HT22 Cells
【24h】

Tacrine-6-Ferulic Acid, a Novel Multifunctional Dimer Against Alzheimer's Disease, Prevents Oxidative Stress-Induced Neuronal Death Through Activating Nrf2/ARE/HO-1 Pathway in HT22 Cells

机译:Tacrine-6-Ferulic Acid,一种新型的针对阿尔茨海默氏病的多功能二聚体,通过激活HT22细胞中的Nrf2 / ARE / HO-1途径,预防氧化应激诱导的神经元死亡。

获取原文
获取原文并翻译 | 示例
           

摘要

Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder with progressive and devastating memory impairment [1]. The majority of therapeutic strategies and drug development approaches for AD were based on dysfunction of acetylcholine to date, which mainly alleviate symptoms of AD [1]. A great amount of researches proposed that oxidative stress (OS) be an important and early factor in the pathogenesis of AD and contribute to beta-amyloid generation [2]. Nuclear factor E2-related factor 2 (Nrf2) is a novel transcription factor known to induce expression of a variety of cytoprotective and detoxification genes. Increasing evidence demonstrated that Nrf2/ARE pathway may be considered a therapeutic target for neurodegenerative diseases, including AD [3].
机译:阿尔茨海默氏病(AD)是一种多因素神经退行性疾病,具有进行性和破坏性的记忆障碍[1]。迄今为止,大多数AD的治疗策略和药物开发方法都是基于乙酰胆碱功能障碍,主要缓解AD症状[1]。大量的研究提出氧化应激(OS)是AD发病机理中的重要且早期的因素,并促进β-淀粉样蛋白的产生[2]。核因子E2相关因子2(Nrf2)是一种新型的转录因子,已知可诱导多种细胞保护和排毒基因的表达。越来越多的证据表明,Nrf2 / ARE途径可能被认为是包括AD在内的神经退行性疾病的治疗靶点[3]。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号